Dual Targeting of Inflammatory and Immune Checkpoint Pathways to Overcome Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma
Zhifeng Qu,1 Linlin Shi,2 Pei Wang,1 Anshun Zhao,2 Xuewei Zheng,3 Qinan Yin1,3 1Department of Radiation Oncology; Cancer Institute, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, People’s Republic of China; 2Henan Key Laborator...
Saved in:
Main Authors: | Qu Z, Shi L, Wang P, Zhao A, Zheng X, Yin Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-07-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/dual-targeting-of-inflammatory-and-immune-checkpoint-pathways-to-overc-peer-reviewed-fulltext-article-JIR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review
by: Yan Lin, et al.
Published: (2025-07-01) -
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355)
by: Xinyi Liu, et al.
Published: (2025-07-01) -
Chemo-immunotherapy sequential with radiotherapy in advanced or metastatic esophageal squamous cell carcinoma
by: Xiang Han, et al.
Published: (2025-12-01) -
Expert consensus on radiotherapy for oligometastatic esophageal cancer (2025 edition)
Published: (2025-06-01) -
Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)